Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Mitacs

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 31
Average round size
info
The average size of a deal this fund participated in
$152K
Portfolio companies 25
Rounds per year 1.24
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.19
Exits 2
Key employees Soon

Areas of investment

  • Medical Device
  • Health Care
  • Artificial Intelligence
  • Personal Health
  • Software

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Mitacs:
Typical Co-investors
Mitacs is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Mitacs:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Background Capital -
Borealis Canada, Magog, Ontario
Capital6 Eagle -
Citrus Ventures California, Encino, United States
Computer Software Association of Japan Chiyoda, Japan
First In Ventures -
First Seafront Fund China, Guangdong, Shenzhen
Hongfu Ruiying China, Guangdong, Shenzhen
L Capital Partners New York, New York, United States
Moonwhale Ventures Delaware, Ohio, United States
New Market Education Partners Fulton, Maryland, United States
OLMA Private Equity Fund County Dublin, Dublin, Ireland
PALgenesis New York, New York, United States
Rambus California, Los Altos, United States
SCP Vitalife Partners Pennsylvania, United States, Wayne
Software Innovation Akershus, Lysaker, Norway
STARTegy Ventures Coahuila, Mexico, Monclova
VIC Partners -
WSR Capital Colorado, Highlands Ranch, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Replica Analytics

Analytics
Information Technology
Software
$1M24 Jun 2020 Ontario

Crowdmark

Artificial Intelligence
Big Data
Education
Machine Learning
Skill Assessment
$11K30 Aug 2012 Old Toronto, Ontario, Canada

OtoSim Inc.

Training
$60K23 Aug 2012 Old Toronto, Ontario, Canada

SinoVeda Canada

Biotechnology
Life Science
Pharmaceutical
$634K01 Oct 2010 Edmonton, Canada

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Mitacs?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 31
Average round size 152K
Rounds per year 1.24
Peak activity year 2022
Lead investments 3
Follow on index 0.19
Exits 2
Group Appearance index 0.39

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Replica Analytics

Analytics
Information Technology
Software
$1M24 Jun 2020 Ontario

Crowdmark

Artificial Intelligence
Big Data
Education
Machine Learning
Skill Assessment
$11K30 Aug 2012 Old Toronto, Ontario, Canada

OtoSim Inc.

Training
$60K23 Aug 2012 Old Toronto, Ontario, Canada

SinoVeda Canada

Biotechnology
Life Science
Pharmaceutical
$634K01 Oct 2010 Edmonton, Canada
Crunchbase icon

Content report

The following text will be sent to our editors: